Short bowel syndrome natural history, complications and prognosis

Jump to navigation Jump to search

Short bowel syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Short bowel syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Short bowel syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Short bowel syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Short bowel syndrome natural history, complications and prognosis

CDC on Short bowel syndrome natural history, complications and prognosis

Short bowel syndrome natural history, complications and prognosis in the news

Blogs on Short bowel syndrome natural history, complications and prognosis

Directions to Hospitals Treating Short bowel syndrome

Risk calculators and risk factors for Short bowel syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
  • The symptoms of (disease name) typically develop ___ years after exposure to ___.
  • If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

Common complications of short bowel syndrome may be classified to different categories, including malnutrition, surgery related, and chronic complications.[1][2][3]

  • Malnutrition
    • Vitamin deficiency
      • Vitamin A deficiency
      • Vitamin B12 deficiency
      • Vitamin C deficiency
      • Vitamin D deficiency
      • Vitamin E deficiency
      • Vitamin K deficiency
    • Mineral deficiency
      • Iron deficiency
      • Folic acid deficiency
      • Calcium deficiency
      • Zinc deficiency
      • Magnesium deficiency
      • Selenium deficiency
      • Copper deficiency
    • Micronutrient deficiency/excess
    • Essential fatty acid deficiency
  • Surgery related complications
    • General complications of surgery
      • Thrombosis
      • Hemorrhage
      • Wound infection
      • Postoperative pulmonary atelectasis
      • Acute kidney injury
      • Pulmonary embolism
      • Deep vein thrombosis
    • Surgery on GI system
      • Anastomotic disruption
      • Anastomotic bleeding
    • Catheter related complications:
      • Infection of the central line
      • Occlusion of the catheter due to thrombosis, fibrin formation, or precipitations
      • Breakage of the central line
    • Post bowel transplant complications:
      • Acute rejection
      • Chronic rejection
      • Hepatic, portal, or mesenteric vein thrombosis
      • Opportunistic infection, such as CMV, ….
  • Chronic complications
    • Gastrointestinal
      • Small intestinal bacterial overgrowth due to stasis
      • Bowel obstruction
      • Bowel motor abnormalities
      • Stasis of intestinal contents
      • Parenteral nutrition liver disease from steatosis to cirrhosis
      • Bowel necrosis
      • Peptic ulcers due to gastric hypersecretion
      • Gallstones due to altered bile salt and bilirubin metabolism
      • Hepatobiliary disease
      • Lactose intolerance
      • Permanent intestinal failure
    • Extra-intestinal
      • Kidney stone due to hyperoxaluria
      • Metabolic bone disease
      • Lactic acidosis 

Prognosis

  • There is no cure for short bowel syndrome.
  • In newborn infants, the 4-year survival rate on parenteral nutrition is approximately 70%. Some studies suggest that much of the mortality is due to a complication of the TPN, especially chronic liver disease.[4]
  • Much hope is vested in Omegaven, a type of lipid TPN feed, in which recent case reports suggest the risk of liver disease is much lower.[5]
  • Although promising, the small intestine transplant has a mixed success rate, with a postoperative mortality rate of up to 30%. One-year and 4-year survival rates are 90% and 60%, respectively.
  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
  • Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

  1. Wall, Elizabeth A. (2013). "An Overview of Short Bowel Syndrome Management: Adherence, Adaptation, and Practical Recommendations". Journal of the Academy of Nutrition and Dietetics. 113 (9): 1200–1208. doi:10.1016/j.jand.2013.05.001. ISSN 2212-2672.
  2. Thompson, Jon S.; Weseman, Rebecca; Rochling, Fedja A.; Mercer, David F. (2011). "Current Management of the Short Bowel Syndrome". Surgical Clinics of North America. 91 (3): 493–510. doi:10.1016/j.suc.2011.02.006. ISSN 0039-6109.
  3. Vanderhoof JA, Young RJ (2003). "Enteral and parenteral nutrition in the care of patients with short-bowel syndrome". Best Pract Res Clin Gastroenterol. 17 (6): 997–1015. PMID 14642862.
  4. Vanderhoof JA, Langnas AN (1997). "Short-bowel syndrome in children and adults". Gastroenterology. 113 (5): 1767–78. PMID 9352883.
  5. Gura KM, Duggan CP, Collier SB; et al. (2006). "Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management". Pediatrics. 118 (1): e197–201. doi:10.1542/peds.2005-2662. PMID 16818533.

Template:WH Template:WS